Skip to content

Added to your cart:

Cart subtotal

Herceptin Hylecta (trastuzumab and Hyaluronidase-Oysk Injection 5 mL (RX) **Refrigeration Required

SKU 50242-0077-01
Sale 19%
Original price $ 7,999.95
Current price $ 6,495.00
*Mountainside Medical does not fill personal prescriptions Medical Professional License Required to Unlock Account

How to Order:

Send an email request to: sales@mountainside-medical.com

You will receive instructions on how to create an account along with Rx Ordering Details.

(Note: Acceptable licenses must have Prescriptive Authority in the license issuing state.)
Fast Delivery
Fast Delivery
24/7 Support
24/7 Support
No Returns
No Returns
Hospital Grade
Hospital Grade
Save 19% ($ 1,504.95)
Free Shipping on orders above $100
Payment Secure transaction
Packaging Ships in product packaging
Service-Disabled Veteran-Owned Small Business
Service-Disabled Veteran-Owned Small Business
Located in Adirondack Mountains in NY
Located in Adirondack Mountains in NY
Family Owned Business 2002
Family Owned Business 2002
Sale 19%
Original price $ 7,999.95
Current price $ 6,495.00
Free Shipping on orders above $100
Payment Secure transaction
Packaging Ships in product packaging
Herceptin Hylecta (trastuzumab and Hyaluronidase-Oysk Injection 5 mL (RX) **Refrigeration Required
Herceptin Hylecta (trastuzumab and Hyaluronidase-Oysk Injection 5 mL (RX) **Refrigeration Required
$ 7,999.95 $ 6,495.00
🔒 Medical License Required
Description

Experience effective breast cancer treatment with Herceptin Hylecta (trastuzumab and Hyaluronidase-Oysk Injection 5 mL), enhancing patient care.

Herceptin Hylecta is a prescription medication used to treat certain types of breast cancer that are HER2-positive. It contains two active ingredients, trastuzumab and Hyaluronidase-Oysk, which work together to block the activity of HER2 proteins, slowing the growth and spread of cancer cells. The medication is administered as an injection under the skin every 3 weeks and the 5 mL refers to the amount of solution in each individual dose.

Herceptin Hylecta is a medication for the treatment of certain types of breast cancer. It is a combination of the drug trastuzumab and the enzyme hyaluronidase.

Trastuzumab is a monoclonal antibody that works by binding to a protein called HER2, which is present in large amounts in some breast cancer cells. By binding to HER2, trastuzumab can slow down or stop the growth and spread of these cancer cells.

Hyaluronidase is an enzyme that helps to break down a substance called hyaluronic acid, which is found in the connective tissues in the body. Hyaluronidase helps to create channels in these tissues, allowing medications like trastuzumab to be more easily absorbed into the bloodstream.

Together, trastuzumab and hyaluronidase work to fight against HER2-positive breast cancer by slowing down tumor growth and potentially shrinking it.

Herceptin Hylecta is administered as an injection under the skin every 3 weeks. It may be used alone or in combination with other cancer treatments, such as chemotherapy or radiation therapy.

Get Notified When Back in Stock